Clay Siegall Continues To Lead Cancer Research

Clay Siegall, CEO and President of Seattle Genetics, is the main source behind the the generous donations into cancer research his organization has received. He is committed to fighting the threat of debilitating diseases and has spoken against the era that included chemotherapy as the only method to fight against cancer. His success lies behind his newly integrated ADCETICS antibody’s that are meant to separate killing cancer cells from killing normal cells because this has been the threat to many cancer patients. Siegall, understands their are unmet needs in cancer research and treatment and has been committed to effective strategies based on his clients needs.

He was once a value member of the big name GlaxoSmith-Kline pharmaceutical company and has been a part of his current co-founded Seattle Genetics organization for over 15+ years. His capital raising initiative has helped Seattle Genetics earn over 1.2 billion dollars for their research defense from public and private financial sources. There is a lot of family’s who suffer each year with a family member that is fighting cancer and have no choice, but to face chemotherapy when there are other options for treatment. Cancer patients no longer have to fight the threat of cancer on their own with integrated advanced medicine designed to save more lives and put cancer into complete remission for thousands of suffers.

You’re invited to learn more about Clay Siegall’s professional career by visiting his exclusive LinkedIn account or the Seattle Genetics website for more details. Be a part of the commitment by Seattle Genetics and Clay Siegall to fight against cancer with less chemotherapy.

This entry was posted in Cancer Research. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *